Perspectives on the FDA’s Sunscreen Policy: New Aging Theory, Sunlight Benefits, Enhanced Immunity, COVID-19 Mortality, Modelling Analyses, Melanoma Risks and Etiology
Journal Title: Journal of Dermatology Research - Year 2021, Vol 2, Issue 1
Abstract
Currently, the U.S. Food and Drug Administration’s policy on sunscreens assumes that exposure to sunlight, mainly ultraviolet (UV) rays, damages the skin, the damage is cumulative and any sun exposure should be avoided or minimized. Sunscreens are approved to help prevent early skin aging, sunburn and skin cancer. This work presents provocative perspectives on some issues related to use of sunscreens shown below. Skin aging is predominantly caused by the intrinsic nutritional factor. Sunlight damage is unlikely cumulative due to extremely efficient self-repair/self-defense mechanisms of the body. Regular exposure to moderate nonburning sunlight increases immunity and protects against sunburn, melanoma, COVID-19 mortality, high blood pressure, etc. White and non-white populations may need sun protection only when the UV Index is ≥ 5-6 and ≥ 7-8, respectively. Modelling analyses suggest that sunscreens with SPF 8 and 2-6 may be adequate for whites and non-whites, respectively. There are inherent risks of sunburn and melanoma when sunscreen is used intermittently mainly due to unavoidable SPF-independent missing applications and may serve as a false security; this may mainly account for exponential increases in melanoma incidences in recent decades; thus, the more intermittent use of sunscreen, the more incidence of sunburn and skin cancer. 10am- 2pm sunlight avoidance guidelines may need modification. Extensive human studies suggest that intense UVB from sunburn, not UVA or sub-erythemal UVB, may cause melanoma; this hypothesis is supported by mouse and fish models. Without exposure to burning sunlight, we may not need to use broad-spectrum sunscreens or UVB-based sunscreens in our daily lives. Potential implications of this work may be immense in terms of saving lives and improving health of consumers, reducing costs associated with marketing and use of sunscreens, as well as reducing environmental pollution.
Authors and Affiliations
Win L Chiou
Keywords
Related Articles
- EP ID EP699061
- DOI http://dx.doi.org/10.46889/JDR.2021.2104
- Views 85
- Downloads 0
ORF Nodule Complicated by Erythema Multiforme: About 2 Cases
ORF nodule is a disease caused by a parapoxvirus ovis with epithelial tropism which is transmitted to humans from sick animals, sheep and goats, suffering from contagious ovine pustular dermatosis ecthyma [1]. Common com...
Tattooing in Young Adults: Patterns, Complications and Reasons for Dermatological Consultation at a Tertiary Care Center
Background: A tattoo is a dermatological procedure in which pigmented dyes are injected into the dermis using needles or a tattooing device, leading to permanent or semi-permanent skin pigmentation. This process may trig...
An Unusual Skin Manifestation by Mycoplasma Pneumoniae without Pulmonary Infection
Pulmonary infections are often caused by Mycoplasma pneumoniae. However, extra pulmonary manifestations are also reported. Mycoplasma pneumonia associated severe mucositis with relative few skin rash has recently been...
Transient Eosinophilic Nodulomatosis: A Report of Two Cases
Transient eosinophilic nodulomatosis is an uncommon disease characterized by multiple nodules in different parts of the body, with spontaneous resolution in an average of 3 weeks. Histological examination shows perivascu...
Superficial Acral Fibromyxoma (SAF): A Case Report
Superficial Acral Fibromyxoma (SAFM) is a benign soft tissue tumor characterized by the presence of stellate and spindle-shaped cells arranged in a storiform and fascicular pattern. This tumor is relatively rare, benign...